Fubon Technology disclosed its 2026 interim report, achieving operating revenue of 674 million yuan, net profit attributable to the parent of 55.15 million yuan, and non-GAAP net profit of 52.72 million yuan. Net cash flow from operating activities turned positive at 18.98 million yuan, compared with a negative 49 million yuan in the same period last year. The company is built on two major business segments, industrial additives and specialty fertilizers, and modern agriculture, and continues to advance the coordinated development of its "macro additives" strategy and its "biology plus digital" technology pathway. During the reporting period, the additives business achieved operating revenue of 493 million yuan, including 202 million yuan from domestic additives and 291 million yuan from overseas additives. The bio segment achieved operating revenue of 127 million yuan, up 3.78 percent year on year, supported by Kangxin Bio and Fubon Xiangyu as its two main platforms, as well as the National Biopesticide Engineering Technology Research Center, and has formed a full industry chain layout from strain selection to formulated products. The specialty fertilizer business achieved operating revenue of 32.33 million yuan, with related programs carrying out field trials and demonstrations across more than 10,000 mu in four major regions: Xinjiang, Northeast China, Inner Mongolia, and Hubei.
Hubei Forbon Technology Co LtdFirst-half revenue and profit reported, with operating cash flow turning positive.
